Skip to main content
Premium Trial:

Request an Annual Quote

Alnylam Adds Infectious Liver Disease Programs to Pipeline


NEW YORK (GenomeWeb) – Alnylam Pharmaceuticals this week announced that it has expanded its pipeline to include programs in chronic hepatitis delta virus (HDV) and chronic liver infections.

HDV is an RNA virus that infects hepatocytes and depends on a co-existing hepatitis B virus infection to produce the envelope particle that holds its genome, the company said. It can be acquired at the same time as HBV or afterward, and results in more severe liver disease than that seen with HBV infection alone.

Alnylam said that its HDV candidate, called ALN-HDV, will be developed as part of a combination therapy with its preclinical HBV agent ALN-HBV, which is slated to enter Phase I testing in 2016.

The firm's chronic liver diseases therapeutic, dubbed ALN-PDL, will target PD-L1, a cell surface protein that is believed to play a major role in suppressing the immune system in cancer and infection. Infection with HBV or hepatitis C increases PD-L1 expression, which potentially suppresses a patient's immune system.

By knocking down PD-L1, Alnylam expects to reactive a suppressed immune system against viral infection, without the toxicities that have been observed with monoclonal antibody approaches against the target.

Both ALN-HDV and ALN-PDL will use Alnylam's proprietary GalNAc conjugate delivery technology, the company said.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.